1. Home
  2. TENX vs GASS Comparison

TENX vs GASS Comparison

Compare TENX & GASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$13.64

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

GASS

StealthGas Inc.

HOLD

Current Price

$8.53

Market Cap

357.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TENX
GASS
Founded
1967
2004
Country
United States
Greece
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
317.8M
357.7M
IPO Year
2001
2005

Fundamental Metrics

Financial Performance
Metric
TENX
GASS
Price
$13.64
$8.53
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
898.1K
151.2K
Earning Date
05-15-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$5.00
Revenue Growth
N/A
N/A
52 Week Low
$5.67
$6.12
52 Week High
$18.38
$10.55

Technical Indicators

Market Signals
Indicator
TENX
GASS
Relative Strength Index (RSI) 67.28 36.89
Support Level $13.16 $7.63
Resistance Level $14.15 $9.80
Average True Range (ATR) 0.72 0.36
MACD 0.30 -0.10
Stochastic Oscillator 99.40 24.96

Price Performance

Historical Comparison
TENX
GASS

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About GASS StealthGas Inc.

StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.

Share on Social Networks: